Related content

A Review of: “Data and Safety Monitoring Committees in Clinical Trials, by J. Herson”

By Gallo Paul  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 1168-1171

Taylor & Francis Ltd

Access to resources Recommend Favorite

Regulatory Perspectives on Data Safety Monitoring Boards: Protecting the Integrity of Data

By Hemmings R.   Day S.  

Drug Safety, Vol. 27, Iss. 1, 2004-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Enhancing the Quality of Laboratory Results in Clinical Trials

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 1, 2014-04 ,pp. : 37-42

Bentham Science Publishers

Access to resources Recommend Favorite

Missing Data in Confirmatory Clinical Trials

By Flyer Paul   Hirman Joseph  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 969-979

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clinical Trials and the Independence of Investigators: A Novel Method for the Conduct of Pharmaceutical Company-Funded Clinical Drug Trials Which Ensures Investigator Independence

By Beran Roy G.   Ainley Laetitia A.E.   Beran Maureen E.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 5-6, 2005-01 ,pp. : 309-316

Adis International

Access to resources Recommend Favorite